Low-Dose Atropine for Myopia Control - American Academy of Ophthalmology
2023年7月1日 · Bullimore and Brennan sought to predict the three-year efficacy of low-dose atropine by assessing results of the low-concentration atropine for myopia progression (LAMP) study and by reviewing a meta-analysis of 80 studies of axial length in untreated myopic children.
How to Use Low-Dose Atropine to Slow Myopic Progression in Kids
2016年12月1日 · Experts discuss their use of low-dose atropine for treatment of rapidly progressing myopia in children. Web Extra: Learn about a possible biomarker for patholog
Low-Dose Atropine to Slow Myopia: Evidence and Adoption Are Growing
2021年8月1日 · Word is spreading that low-dose atropine is proving to be a worthwhile solution to childhood myopia—pediatricians, optometrists, and primary care physicians are referring patients specifically for this type of treatment, said Dr. Epley.
The Role of Atropine in Preventing Myopia Progression: An Update
To date, atropine has shown promising results in preventing myopia progression. In particular, lower doses of atropine have revealed the most advantageous in balancing between clinical efficacy and the low rate of adverse effects, even though a rebound phenomenon after the interruption of the treatment has been reported [9].
Which low‐dose atropine for myopia control? - PMC
2019年9月5日 · A recent report in the Community Eye Health Journal,7 widely accessible in developing countries, proposes 0.01% atropine as the recommended treatment for childhood myopia control, and in India, the Mumbai Group of Paediatric Ophthalmologists and Strabismologists also recommends 0.01% atropine for treating childhood myopia, with almost two ...
Efficacy and Safety of 8 Atropine Concentrations for Myopia Control …
2021年6月12日 · High-dose atropine showed lower-ranking probabilities for 3 safety outcomes (i.e., photopic and mesopic pupil diameter, accommodation amplitude) compared with low-dose atropine. Several meta-analyses have investigated various concentrations of …
Efficacy and safety of atropine to control myopia progression: a ...
2020年12月7日 · A low dose of atropine worsened the progression of myopia. 0.5 and 1.0% of atropine could safely and effectively control the progression of low to moderate myopia . However, the meta-analysis done by Song et al. only included 6 studies in 2011.
Efficacy and Safety of Low-Dose Atropine on Myopia Prevention …
Abstract. Background: Early-onset myopia increases the risk of irreversible high myopia.Methods: This study systematically evaluated the efficacy and safety of low-dose atropine for myopia control in children with premyopia through meta-analysis using random-effects models. Effect sizes were calculated using risk ratios (RRs) with 95% confidence intervals (CIs).
Atropine, 0.01%, for Myopia Control | Ophthalmology | JAMA ...
Overall, clinical trials investigating atropine, 0.01%, for myopia control, including the well-done study by Repka et al, 7 indicate that stronger concentrations of atropine should be considered for first-line treatment of myopia progression, especially when considering eye growth outcomes in …
Efficacy in Myopia Control: The Low-Concentration Atropine for Myopia ...
2022年11月17日 · The 3-year Low-Concentration Atropine for Myopia Progression (LAMP) study has greatly enhanced knowledge of the use of low-concentration atropine for myopia control. 1,2 In year 1, children were randomized to receive 0.05%, 0.025%, or 0.01% atropine, or placebo. 1 Compared with the placebo, axial elongation was slowed 0.21, 0.12, and 0.05 mm by ...
- 某些结果已被删除